Reaction
Hypopyon reporting signals
As of the last recalculation, Hypopyon appears in 821 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is MOXIFLOXACIN HYDROCHLORIDE (PRR 115.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Moxifloxacin Hydrochloride | 83 | 115.3 | 115.8 |
| Faricimab | 34 | 110.9 | 111.4 |
| Aflibercept | 113 | 106.3 | 106.7 |
| Prednisolone Acetate | 35 | 89.5 | 89.8 |
| Moxifloxacin | 41 | 77.6 | 77.8 |
| Ranibizumab | 54 | 55.1 | 55.2 |
| Tobramycin Solution | 24 | 52.1 | 52.3 |
| Tobramycin Sulfate | 24 | 50.6 | 50.7 |
| Atropine Sulfate | 13 | 31.0 | 31.0 |
| Tobramycin | 27 | 29.4 | 29.4 |
| Cenegermin-Bkbj | 12 | 25.5 | 25.5 |
| Cefuroxime | 11 | 24.7 | 24.7 |
| Triamcinolone Acetonide | 28 | 23.8 | 23.8 |
| Atropine | 7 | 21.6 | 21.6 |
| Gentamicin | 10 | 19.6 | 19.6 |
| Gentamicin Sulfate | 11 | 17.9 | 17.9 |
| Dorzolamide Hydrochloride And Timolol Maleate | 5 | 16.1 | 16.1 |
| Timolol | 6 | 12.7 | 12.7 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 3 | 7.6 | 7.6 |